Apyx Medical Corporation (APYX)

NASDAQ: APYX · IEX Real-Time Price · USD

1.450

-0.030 (-2.03%)

At close: Apr 26, 2024, 4:00 PM

1.400

-0.050 (-3.45%)

After-hours: Apr 26, 2024, 4:06 PM EDT

Apyx Medical Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013 - 1997
Cash & Equivalents	43.65	10.19	30.87	41.92	58.81	16.67	10.76	15.34	12.77	6.63	Upgrade
Short-Term Investments	0	0	0	0	0	61.68	0	0	0	0	Upgrade
Cash & Cash Equivalents	43.65	10.19	30.87	41.92	58.81	78.35	10.76	15.34	12.77	6.63	Upgrade
Cash Growth	328.30%	-66.98%	-26.35%	-28.73%	-24.93%	628.13%	-29.87%	20.18%	92.51%	-16.30%	Upgrade
Receivables	14.05	10.7	13.52	9.67	9.22	5.08	4.86	4.73	2.93	1.99	Upgrade
Inventory	9.92	11.8	6.78	4.05	5.07	5.3	4.27	6.16	5.96	5.73	Upgrade
Other Current Assets	2.73	10.28	9.57	10.45	3.63	1.11	2.66	0.3	0.39	1.01	Upgrade
Total Current Assets	70.36	42.97	60.74	66.09	76.73	89.84	22.55	26.54	22.04	15.37	Upgrade
Property, Plant & Equipment	7.15	7.59	6.87	7.22	7.62	5.79	6.03	6.45	6.81	6.95	Upgrade
Goodwill and Intangibles	0	0	0	0	0	0.19	0.25	1.91	2.02	1.94	Upgrade
Other Long-Term Assets	1.73	1.22	1.11	0.81	0.39	0.11	2.16	0.21	0.58	0.58	Upgrade
Total Long-Term Assets	8.88	8.8	7.98	8.02	8.01	6.09	8.44	8.57	9.41	9.47	Upgrade
Total Assets	79.24	51.78	68.72	74.11	84.75	95.93	30.99	35.11	31.45	24.83	Upgrade
Accounts Payable	2.71	2.67	2.63	1.51	2.44	1.42	1.58	1.61	1.21	1.55	Upgrade
Deferred Revenue	1.25	1.41	1.32	0.62	0.41	0	0	0	0	0	Upgrade
Current Debt	0.37	0.25	0.29	0.36	0.48	0	0.24	0.24	0.24	0.24	Upgrade
Other Current Liabilities	8.42	7.52	8.96	6.66	8.99	7.19	4.15	3.43	2.67	1.97	Upgrade
Total Current Liabilities	12.74	11.85	13.21	9.15	12.31	8.61	5.97	5.27	4.12	3.77	Upgrade
Long-Term Debt	38.13	0.54	0.02	0.31	0.66	0.14	2.6	2.83	3.07	3.17	Upgrade
Other Long-Term Liabilities	1.44	1.59	1.49	0.79	0.52	0	0.39	0.78	0.85	13.2	Upgrade
Total Long-Term Liabilities	39.58	2.13	1.51	1.1	1.18	0.14	2.98	3.62	3.92	16.37	Upgrade
Total Liabilities	52.32	13.98	14.71	10.25	13.49	8.75	8.96	8.89	8.04	20.14	Upgrade
Total Debt	38.5	0.8	0.31	0.68	1.13	0.14	2.83	3.07	3.31	3.41	Upgrade
Debt Growth	4736.81%	160.98%	-54.88%	-40.34%	709.29%	-95.06%	-7.78%	-7.24%	-2.90%	4.76%	Upgrade
Retained Earnings	-54.45	-35.74	-12.55	2.62	14.52	34.22	-28.5	-23.43	-19.48	-27.85	Upgrade
Shareholders' Equity	26.7	37.58	53.7	63.72	71.26	87.18	22.03	26.22	23.4	1.5	Upgrade
Net Cash / Debt	5.15	9.4	30.57	41.24	57.68	78.21	7.93	12.27	9.45	3.22	Upgrade
Net Cash / Debt Growth	-45.18%	-69.26%	-25.88%	-28.50%	-26.25%	886.71%	-35.41%	29.80%	193.60%	-31.00%	Upgrade
Net Cash Per Share	0.15	0.27	0.89	1.21	1.69	2.28	0.25	0.45	0.34	0.18	Upgrade
Working Capital	57.62	31.12	47.53	56.94	64.42	81.22	16.57	21.27	17.92	11.6	Upgrade
Book Value Per Share	0.77	1.09	1.56	1.86	2.09	2.63	0.70	0.96	0.96	0.09	Upgrade

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).